Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer
Authors:
Open Access
- 7 June 2006
- journal article
- research article
- Published by Springer Nature in Gastric Cancer
- Vol. 9 (2) , 106-113
Abstract
Tissue inhibitor of metalloproteinase-1 (TIMP-1) correlates with tumor progression in patients with gastric cancer; however, the clinical significance of TIMP-1 as a marker for prognosis and recurrence has not been fully clarified.Keywords
This publication has 44 references indexed in Scilit:
- Upregulation of the Tissue Inhibitor of Metalloproteinase-1 Protein Is Associated With Progression of Human Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast CancerClinical Cancer Research, 2004
- Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survivalEuropean Journal of Cancer, 2004
- LOCALIZATION AND EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IN HUMAN UROTHELIAL CANCERJournal of Urology, 2002
- LOCALIZATION AND EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 IN HUMAN UROTHELIAL CANCERJournal of Urology, 2002
- Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinomaBritish Journal of Surgery, 2001
- In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.Journal of Clinical Investigation, 1998
- Matrix metalloproteinases and their inhibitors in gastric cancerGut, 1998
- Collagenase activity and tissue inhibitor of metalloproteinases‐1 (TIMP‐1) content in human whole saliva from clinically healthy and periodontally diseased subjectsJournal of Periodontal Research, 1994
- Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activityNature, 1985